|
🐜
|
Characteristics of Hodgkin's disease-derived cell lines.
12 auth.
Diehl,
H. Kirchner,
H. Burrichter,
H. Stein,
C. Fonatsch,
J. Gerdes,
...
M. Schaadt,
W. Heit,
B. Uchánska‐Ziegler,
A. Ziegler,
F. Heintz,
K. Sueno
|
7 |
1982 |
7
🐜
|
|
🦁
|
Production of colony‐stimulating factors by Hodgkin cell lines
H. Burrichter,
W. Heit,
Michael Schaadt,
H. Kirchner,
V. Diehl
|
5 |
1983 |
5
🦁
|
|
🐬
|
Cytogenetic investigations in Hodgkin's disease: I. Involvement of specific chromosomes in marker formation.
C. Fonatsch,
V. Diehl,
M. Schaadt,
H. Burrichter,
H. Kirchner
|
5 |
1986 |
5
🐬
|
|
🐬
|
Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number.
J. Stachowski,
M. Pollok,
H. Burrichter,
C. Spithaler,
C. Baldamus
|
5 |
1993 |
5
🐬
|
|
🐬
|
Behavior of lymphocyte subsets and expression of activation markers in response to immunotherapy with galactoside-specific lectin from mistletoe in breast cancer patients
J. Beuth,
H. Ko,
H. Gabius,
H. Burrichter,
K. Oette,
G. Pulverer
|
5 |
1992 |
5
🐬
|
|
🐜
|
Phenotypic and genotypic analysis of Hodgkin's disease derived cell lines: histopathological and clinical implications.
7 auth.
V. Diehl,
M. Pfreundschuh,
C. Fonatsch,
H. Stein,
M. Falk,
H. Burrichter,
...
M. Schaadt
|
5 |
1985 |
5
🐜
|
|
🐜
|
Hodgkin's cell lines: Characteristics and possible pathogenetic implications
9 auth.
Volker Diehl,
H. Burrichter,
M. Schaadt,
H. Kirchner,
C. Fonatsch,
H. Stein,
...
J. Gerdes,
W. Heit,
A. Ziegler
|
4 |
2007 |
4
🐜
|
|
🐬
|
Interleukin-1-like activity constitutively generated by Hodgkin derived cell lines. I. Measurement in a human lymphocyte co-stimulator assay.
C. Kortmann,
H. Burrichter,
D. Monner,
G. Jahn,
V. Diehl,
H. Peter
|
4 |
1984 |
4
🐬
|
